e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Airway disease-associated exacerbations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom)
Source:
International Congress 2019 – Airway disease-associated exacerbations
Session:
Airway disease-associated exacerbations
Session type:
Thematic Poster
Number:
4282
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom). Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort. 4282
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021
Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort
Source: International Congress 2019 – Exacerbations of airway diseases
Year: 2019
Factors associated with exacerbations in patients with COPD: NOVELTY study
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
One-year exacerbation frequency and treatment in the ECLIPSE study cohort
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Factors acting on the duration of hospitalization in COPD
Source: International Congress 2017 – What is new in COPD diagnosis and classification?
Year: 2017
External validation of two prognostic scores predicting exacerbations in ECLIPSE COPD patients
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020
Identification of factors associated with exacerbation risk in severe COPD: Multivariate analysis of the WISDOM study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Factors associated with exacerbations in US patients with COPD
Source: Annual Congress 2009 - Exacerbations and characteristics of COPD
Year: 2009
Factors associated with one-year mortality in hospitalized patients with exacerbation of bronchiectasis.
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Estimation of a disease progression model for COPD using data from the ECLIPSE study
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017
Factors associated with mortality in the TORCH trial in COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 356s
Year: 2007
One-year survival in patients hospitalized due to an acute exacerbation of COPD. Related factors
Source: Annual Congress 2009 - COPD: exacerbation and clinical problems
Year: 2009
Factors associated with COPD exacerbation frequency in a UK primary care cohort
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002
COPD exacerbation admissions: Analysis of demographics and mortality
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Factors associated with physician assessment of severity of asthma or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases
Year: 2020
Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Factors affecting survival after severe COPD exacerbations: a single-center experience.
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020
Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort
Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept